Abstract

ESRA19-0707 Use of intralipid to limit side effects of excessively high blocks or unwanted excessive duration of action?

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call